{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:59:59Z","timestamp":1785419999585,"version":"3.56.0"},"reference-count":23,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"China National Biotech Group Co., Ltd.","award":["KTZC1200006B"],"award-info":[{"award-number":["KTZC1200006B"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: An assay for protein content is essential but insufficient for quality control of acellular pertussis vaccines, which might consist of up to five components, each needing individual quantification. Generally, purified pertussis antigens such as pertussis toxin (PTx), filamentous haemagglutinin (FHA), and pertactin (PRN) should be detoxified or stabilized chemically before being formulated into vaccine bulk. The use of chemical agents like formaldehyde and glutaraldehyde can alter the immunological reactivity of these antigens, rendering direct assays by methods such as ELISA ineffective. Methods: In this study, a simple method based on single radial diffusion (SRD) using low concentrations of polyclonal antisera against PT toxoid (PTd), FHA, and PRN was developed. By adding a detergent, diffusible subunits are produced regardless of the original physical state of the antigens, making it suitable for quantifying these antigens after chemical treatment. Results: The assay has shown good specificity, accuracy, and precision. Furthermore, it can differentiate between preparations with the same protein concentration but different antigenic contents. A significant positive correlation between the antigen content and the in vivo immunogenicity has also been demonstrated. Conclusions: An assay for quality control and consistency monitoring of combined vaccines containing acellular pertussis antigen components has been established.<\/jats:p>","DOI":"10.3390\/vaccines13020116","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T03:26:31Z","timestamp":1737689191000},"page":"116","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development and Implementation of a Single Radial Diffusion Technique for Quality Control of Acellular Pertussis Vaccines"],"prefix":"10.3390","volume":"13","author":[{"given":"Chongyang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Research and Development, Beijing Institute of Biological Products Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Beijing Institute of Biological Products Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Bacterial Vaccine Manufacturing Facility, Beijing Institute of Biological Products Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshuo","family":"Zhu","sequence":"additional","affiliation":[{"name":"Bacterial Vaccine Manufacturing Facility, Beijing Institute of Biological Products Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[{"name":"Bacterial Vaccine Manufacturing Facility, Beijing Institute of Biological Products Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-3496","authenticated-orcid":false,"given":"Wenming","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Beijing Institute of Biological Products Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Zhang","sequence":"additional","affiliation":[{"name":"China National Biotec Group Co., Ltd., Beijing 100024, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.cmi.2016.05.029","article-title":"Live pertussis vaccines: Will they protect against carriage and spread of pertussis?","volume":"22","author":"Locht","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Smout, E., Mellon, D., and Rae, M. (2024). Whooping cough rises sharply in UK and Europe. BMJ, 385.","DOI":"10.1136\/bmj.q736"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1473-3099(17)30390-0","article-title":"An update of the global burden of pertussis in children younger than 5 years: A modelling study","volume":"17","author":"Yeung","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-3836","article-title":"Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers","volume":"131","author":"Klein","year":"2013","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2015.05.008","article-title":"Pertussis vaccines and the challenge of inducing durable immunity","volume":"35","author":"Warfel","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Klein, N.P., Bartlett, J., Fireman, B., and Baxter, R. (2016). Waning Tdap Effectiveness in Adolescents. Pediatrics, 137.","DOI":"10.1542\/peds.2015-3326"},{"key":"ref_8","unstructured":"Plotkin, S., Orenstein, W., and Offit, P.A. (2018). Plotkin\u2019s Vaccines, Elsevier."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.vaccine.2016.03.007","article-title":"Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines","volume":"34","author":"Yuen","year":"2016","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0264-410X(03)00104-X","article-title":"Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: Effects on toxicity and immunogenicity","volume":"21","author":"Fowler","year":"2003","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/CVI.00561-10","article-title":"Antibodies Recognizing Protective Pertussis Toxin Epitopes Are Preferentially Elicited by Natural Infection versus Acellular Immunization","volume":"18","author":"Sutherland","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0264-410X(95)00230-X","article-title":"The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies","volume":"14","author":"Ibsen","year":"1996","journal-title":"Vaccine"},{"key":"ref_13","unstructured":"(2014). Recommendations to Assure the Quality, Safety and Efficacy of Acellular Pertussis Vaccines, Annex 4, TRS No 979, World Health Organization."},{"key":"ref_14","first-page":"223","article-title":"A single radial immunodiffusion technique for the assay of influenza hae-mag-glutinin antigen: Proposals for an assay method for the haemagglutinin content of influenza vaccines","volume":"52","author":"Schild","year":"1975","journal-title":"Bull WHO"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J. Biol. Stand."},{"key":"ref_16","first-page":"27","article-title":"Collaborative study on a Guinea pig serological method for the assay of acellular pertussis vaccines","volume":"1","author":"Winsnes","year":"2009","journal-title":"Pharmeur. Bio Sci. Notes"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Guo, Y., Dong, Y., Liu, Y., Zhao, Y., Yu, S., Li, S., Wu, C., Yang, B., and Li, W. (2022). Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models. Hum. Vaccines Immunother., 18.","DOI":"10.1080\/21645515.2022.2160158"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41579-024-01064-8","article-title":"Pertussis vaccines, epidemiology and evolution","volume":"22","author":"Rohani","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Esposito, S., Stefanelli, P., Fry, N.K., Fedele, G., He, Q., Paterson, P., Tan, T., Knuf, M., Rodrigo, C., and Olivier, C.W. (2019). Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01344"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1021\/bi901532z","article-title":"Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7","volume":"48","author":"Sutherland","year":"2009","journal-title":"Biochemistry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1128\/iai.59.10.3832-3835.1991","article-title":"Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies","volume":"59","author":"Sato","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/biol.1998.0145","article-title":"Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin","volume":"26","author":"Xing","year":"1998","journal-title":"Biologicals"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/2\/116\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:35:09Z","timestamp":1759919709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/2\/116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["vaccines13020116"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13020116","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}